Promising Results from CBD for Epilepsy Patients
For over a decade, parents of children with seizure-causing disorders have taken matters into their own hands. Unwilling to allow their children to suffer through ineffective pharmaceuticals with horrific side effects, these heroes quite literally broke the law by creating CBD oil in their kitchens and administering it. The results reported have been nothing short of phenomenal. Children suffering from Lennox-Gastaut or Dravet Syndromes who were regularly treated with CBD oil reportedly saw occurrences of drop seizures reduced by more than half. As word spread, the practice became common and so did anecdotes of amazing results.
CBD for Epileptic Seizures
After ten years, medical research finally confirmed what was already obvious: CBD is extremely effective in controlling seizures in both children and adults. But that’s not to say there aren’t obstacles that need to be overcome before doctor’s begin to prescribe it across the country.
Side Effects of CBD Oil For Epilepsy Treatment
Some of the reported side effects of CBD are dry mouth, low blood pressure, light-headedness, and drowsiness. When compared to the common side effects of epilepsy medications (dizziness, fatigue, nausea, vomiting, vertigo, depression, drooling, hyperactivity, tremors, ataxia, distressed vision) and some that are less common but pretty horrible (bone-thinning, hearing loss, liver damage, decreased platelet count and pancreas problems) CBD seems like a sensible choice for a primary treatment.
FDA Approval for CBD For Seizures
In 2016, the FDA “fast-tracked” Epidolex, a drug using synthetic CBD to control seizures caused by epilepsy. Many clinical studies on the drug have shown positive results, and the drug could be ready for market as soon as October of 2018. Though the drug’s formula is proprietary, CBD seems to be the only active ingredient. Because cannabis in its natural form is illegal on the federal level, only synthetic CBD is eligible for approval.
Some critics question the ethics of a drug company profiting from a therapy that is inexpensive but illegal to produce at home. Others argue that synthesizing a chemical that exists in nature is illogical, as it requires far more energy and resources to produce CBD artificially than it would take to grow the same amount from industrial hemp. Still, the benefits of a federal organization acknowledging the effectiveness of a compound found in marijuana as a medical treatment are far-reaching. It puts a rather sizable hole in the federal government’s stance that cannabis is a schedule 1 controlled substance – A designation assigned only to substances with “no medical usefulness.” And, more importantly, this may open the door for much-needed research into the other compounds found in cannabis and their potential applications in human health.